<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Exicure, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Exicure, Inc.

    Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs against validated targets. Exicure's proprietary 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of therapeutic oligonucleotides in a wide range of cells and tissues. Exicure's lead programs address oncology, inflammatory diseases and genetic disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      David A. Giljohann
    • FOUNDED
      2009
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Orthofix Medical Inc.

    Orthofix Medical Inc.

    ​​Orthofix Medical Inc. is a diversified, global medical device company focuse...

    ​​Orthofix Medical Inc. is a diversified, g...

    Filing Type:    PU
    PatientDirected Inc.

    PatientDirected Inc.

    Unique and disruptive, PatientDirected.io benefits the patient first. It intends t...

    Unique and disruptive, PatientDirected.io benef...

    Fundraising Status:    EC
    Filing Type:    CF
    Valeritas Holdings, Inc.

    Valeritas Holdings, Inc.

    Valeritas is a commercial-stage medical technology company focused on improving he...

    Valeritas is a commercial-stage medical technol...

    Filing Type:    PU
    Neurotrope, Inc.

    Neurotrope, Inc.

    Neurotrope is a clinical-stage biotech company leveraging Bryostatin-1 and its ana...

    Neurotrope is a clinical-stage biotech company ...

    Filing Type:    PU
    Neurocrine Biosciences, Inc.

    Neurocrine Biosciences, Inc.

    Neurocrine Biosciences (Nasdaq: NBIX) is a neuroscience-focused, biopharmaceutical...

    Neurocrine Biosciences (Nasdaq: NBIX) is a neur...

    Filing Type:    PU
    Neoleukin Therapeutics, Inc.

    Neoleukin Therapeutics, Inc.

    Neoleukin is a biopharmaceutical company creating next generation immunotherapies ...

    Neoleukin is a biopharmaceutical company creati...

    Filing Type:    PU
    Epizyme, Inc.

    Epizyme, Inc.

    Epizyme, Inc. is a clinical stage biopharmaceutical company creating novel epigene...

    Epizyme, Inc. is a clinical stage biopharmaceut...

    Filing Type:    PU
    Unum Therapeutics Inc.

    Unum Therapeutics Inc.

    Unum Therapeutics is a clinical-stage biopharmaceutical company focused on develop...

    Unum Therapeutics is a clinical-stage biopharma...

    Filing Type:    PU
    DermTech, Inc.

    DermTech, Inc.

    DermTech is the global leader in molecular dermatology, bringing precision medicin...

    DermTech is the global leader in molecular derm...

    Filing Type:    PU
    Equillium, Inc.

    Equillium, Inc.

    Equillium is a biotechnology company leveraging deep understanding of immunobiolog...

    Equillium is a biotechnology company leveraging...

    Filing Type:    PU
    Corbus Pharmaceuticals Holdings, Inc.

    Corbus Pharmaceuticals Holdings, Inc.

    Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical c...

    Corbus Pharmaceuticals Holdings, Inc. is a Phas...

    Filing Type:    PU
    Provention Bio, Inc.

    Provention Bio, Inc.

    Provention Bio, Inc. is a clinical-stage biopharmaceutical company developing nove...

    Provention Bio, Inc. is a clinical-stage biopha...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.